Yusuke Kuwahara
4PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 15, 2025
Publisher Correction: HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.Salvatore Siena, Kanwal Raghav, Toshiki Masuishi
|Dec 16, 2024
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer.Shigehiro Koganemaru, Shohei Koyama, Fumitaka Suto
|Nov 25, 2024
HER2-related biomarkers predict clinical outcomes with trastuzumab deruxtecan treatment in patients with HER2-expressing metastatic colorectal cancer: biomarker analyses of DESTINY-CRC01.Salvatore Siena, Kanwal Raghav, Toshiki Masuishi
|May 14, 2024
Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial.Kohei Shitara, Yung-Jue Bang, Satoru Iwasa
Pageof 1
Frequent Collaborators
4 joint publications
Fumitaka Suto
3 joint publications
Hisato Kawakami
3 joint publications
Makito Koga
2 joint publications
Kohei Shitara
2 joint publications
Takayuki Yoshino
2 joint publications
Salvatore Siena
2 joint publications
Kanwal Raghav
2 joint publications
Toshiki Masuishi
2 joint publications
Elena Elez
2 joint publications
Ian Chau
